Advanced search
Publication Cover
Journal of Asthma and Allergy Volume 11, 2018 - Issue
Submit an article Journal homepage
811
Views
204
CrossRef citations to date
0
Altmetric
Original Research

Adverse outcomes from initiation of systemic corticosteroids for asthma: long-term observational study

David B Price1 Observational and Pragmatic Research Institute, Singapore, Singapore, [email protected];2 Academic Primary Care, Division of Applied Health Sciences, University of Aberdeen, Aberdeen, UK, [email protected]Correspondence[email protected]
,
Frank Trudo3 Medical Affairs, AstraZeneca, Wilmington, DE, USA
,
Jaco Voorham1 Observational and Pragmatic Research Institute, Singapore, Singapore, [email protected]
,
Xiao Xu4 Global Payer Evidence and Pricing, AstraZeneca, Gaithersburg, MD, USA
,
Marjan Kerkhof1 Observational and Pragmatic Research Institute, Singapore, Singapore, [email protected]
,
Joanna Ling Zhi Jie1 Observational and Pragmatic Research Institute, Singapore, Singapore, [email protected]
&
Trung N Tran5 Medical Evidence and Observational Research, AstraZeneca, Gaithersburg, MD, USA
 show all
Pages 193-204 | Published online: 29 Aug 2018

Citations (204)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (39)

Gary Tse, Benjamin Emmanuel, Cono Ariti, Mona Bafadhel, Alberto Papi, Victoria Carter, Jiandong Zhou, Derek Skinner, Xiao Xu, Hana Müllerová & David Price. (2023) A Long-Term Study of Adverse Outcomes Associated With Oral Corticosteroid Use in COPD. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 2565-2580.
Read now
Sunyeob Choi & Bomi Kim. (2023) Comparison of the prevalence and risk factors of chronic allergic diseases before and after COVID-19: using raw data from the Korea National Health and Nutrition Examination Survey in 2019 and 2021. Journal of Asthma 60:12, pages 2093-2103.
Read now
L. Klimek, J. Hagemann, T. Huppertz, F. Bärhold, T. Albrecht, F. Klimek, I. Casper, M. Cuevas, C. Bergmann & S. Becker. (2023) COVID-19 and chronic rhinosinusitis: management and comorbidity – what have we learned?. Expert Review of Clinical Immunology 19:11, pages 1399-1406.
Read now
Margherita Perlato, Valentina Mecheri, Emanuele Vivarelli, Matteo Accinno, Alessandra Vultaggio & Andrea Matucci. (2023) “Patient remodeling” as a consequence of uncontrolled and prolonged OCS use in severe asthma: how biologic therapy can reverse a dangerous trend. Journal of Asthma 0:0, pages 1-4.
Read now
Angelica Tiotiu, Andras Bikov, Francisco-Javier Gonzalez-Barcala, Silviya Novakova, Plamena Novakova, Herberto Chong-Neto, Pierachille Santus, Ignacio Ansotegui, Juan Carlos Ivancevich, Krzysztof Kowal, Stefan Mihaicuta, Denislava Nedeva, Gorgio Walter Canonica, Jonathan A. Bernstein, Louis Philippe Boulet & Fulvio Braido. (2023) Criteria to evaluate efficacy of biologics in asthma: a Global Asthma Association survey. Expert Review of Respiratory Medicine 17:6, pages 507-516.
Read now
Gerard Nicholas Lim, John Carson Allen, Pei Yee Tiew, Wenjia Chen & Mariko Siyue Koh. (2023) Healthcare utilization and health-related quality of life of severe asthma patients in Singapore. Journal of Asthma 60:5, pages 969-980.
Read now
Xavier Muñoz Gall, Javier Domínguez-Ortega, Silvia Pascual, Carlos Cabrera López, Gustavo Resler, Javier Nuevo & Gema Monteagudo. (2023) Clinical burden related to oral corticosteroid treatment of severe asthma in Spain: LEVANTE study. Journal of Asthma 60:5, pages 890-899.
Read now
Peter A. B. Wark, Mark Hew, Yang Xu, Clare Ghisla, Tra-My Nguyen, Bora Erdemli, Aditya Samant & Cassandra Nan. (2023) Regional variation in prevalence of difficult-to-treat asthma and oral corticosteroid use for patients in Australia: heat map analysis. Journal of Asthma 60:4, pages 727-736.
Read now
Andrea Matucci, Emanuele Vivarelli, Susanna Bormioli, Nencini Francesca, Fabio Chiccoli, Mecheri Valentina, Grosso Francesca, Rossi Oliviero, Paola Parronchi & Alessandra Vultaggio. (2023) Long-term retention rate of mepolizumab treatment in severe asthma: a 36-months real-life experience. Journal of Asthma 60:1, pages 158-166.
Read now
Sarah Tamene, Kim Dalhoff, Peter Schwarz, Vibeke Backer & Kasper Aanaes. (2023) Systemic corticosteroids in treatment of chronic rhinosinusitis—A systematic review. European Clinical Respiratory Journal 10:1.
Read now
Kerry L Hancock, Sinthia Bosnic-Anticevich, John D Blakey, Mark Hew, Li Ping Chung, Biljana Cvetkovski, Scott Claxton, Peter Del Fante, Eve Denton, Joe Doan, Kanchanamala Ranasinghe, Lucy Morgan, Anita Sharma, Peter K Smith, Deb Stewart, Philip J Thompson, Russell Wiseman, John W Upham, Kwok Y Yan, Victoria Carter, Kiranjeet Dhillon, Florian Heraud, Thao Le, Rebecca Vella & David Price. (2022) Characterisation of the Australian Adult Population Living with Asthma: Severe - Exacerbation Frequency, Long-Term OCS Use and Adverse Effects. Pragmatic and Observational Research 13, pages 43-58.
Read now
Gianenrico Senna, Maria Aliani, Elena Altieri, Pietro Bracciale, Luisa Brussino, Maria Filomena Caiaffa, Paolo Cameli, Giorgio Walter Canonica, Cristiano Caruso, Maria D’Amato, Fausto De Michele, Stefano Del Giacco, Fabiano Di Marco, Francesco Menzella, Girolamo Pelaia, Paola Rogliani, Micaela Romagnoli, Pietro Schino, Jan Walter Schroeder, Alessandra Vultaggio, Sara Rizzoli, Alessandro Zullo, Silvia Boarino, Marilena Palmisano, Alessandra Rossi, Gianfranco Vitiello & Stefano Centanni. (2022) Clinical Features and Efficacy of Benralizumab in Patients with Blood Eosinophil Count Between 300 and 450 Cells/mm3: A Post Hoc Analysis from the ANANKE Study. Journal of Asthma and Allergy 15, pages 1593-1604.
Read now
Wenjia Chen, Mohsen Sadatsafavi, Trung N Tran, Ruth B Murray, Chong Boon Nigel Wong, Nasloon Ali, Cono Ariti, Esther Garcia Gil, Anthony Newell, Marianna Alacqua, Mona Al-Ahmad, Alan Altraja, Riyad Al-Lehebi, Mohit Bhutani, Leif Bjermer, Anne Sofie Bjerrum, Arnaud Bourdin, Lakmini Bulathsinhala, Anna von Bülow, John Busby, Giorgio Walter Canonica, Victoria Carter, George C Christoff, Borja G Cosio, Richard W Costello, J Mark FitzGerald, João A Fonseca, Kwang Ha Yoo, Liam G Heaney, Enrico Heffler, Mark Hew, Ole Hilberg, Flavia Hoyte, Takashi Iwanaga, David J Jackson, Rupert C Jones, Mariko Siyue Koh, Piotr Kuna, Désirée Larenas-Linnemann, Sverre Lehmann, Lauri A Lehtimäki, Juntao Lyu, Bassam Mahboub, Jorge Maspero, Andrew N Menzies-Gow, Concetta Sirena, Nikolaos Papadopoulos, Andriana I Papaioannou, Luis Pérez de Llano, Diahn-Warng Perng, Matthew Peters, Paul E Pfeffer, Celeste M Porsbjerg, Todor A Popov, Chin Kook Rhee, Sundeep Salvi, Camille Taillé, Christian Taube, Carlos A Torres-Duque, Charlotte S Ulrik, Seung Won Ra, Eileen Wang, Michael E Wechsler & David B Price. (2022) Characterization of Patients in the International Severe Asthma Registry with High Steroid Exposure Who Did or Did Not Initiate Biologic Therapy. Journal of Asthma and Allergy 15, pages 1491-1510.
Read now
Njira Lugogo, Bradley E Chipps, Reynold A Panettieri Jr, Frank Trudo & Christopher S Ambrose. (2022) Long-Term Use of Maintenance Systemic Corticosteroids is Associated with Multiple Adverse Conditions in a Large, Real-World Cohort of US Adults with Severe Asthma. Journal of Asthma and Allergy 15, pages 1753-1761.
Read now
Laren D Tan, Nolan Nguyen, Abdullah Alismail & Mario Castro. (2022) Management of Uncontrolled Asthma: A Framework for Novel and Legacy Biologic Treatments. Journal of Asthma and Allergy 15, pages 875-883.
Read now
Carol Bazell, Michael Pollack, Alejandro P Comellas, Sanjay Sethi, Maggie Alston, Bruce Pyenson, Dane Hansen, Melissa Caplen, Anthony Staresinic, John Styczynski & Norbert Feigler. (2022) A 4-Year Retrospective Claims Analysis of Oral Corticosteroid Use and Health Conditions in Newly Diagnosed Medicare FFS Patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 2635-2652.
Read now
Lauri Lehtimäki, Monica Arvidsson, Bora Erdemli, Cassandra Nan, Tra-My Nguyen, Aditya Samant & Gunilla Telg. (2022) Regional variation in intensity of inhaled asthma medication and oral corticosteroid use in Denmark, Finland, and Sweden. European Clinical Respiratory Journal 9:1.
Read now
Christine Wang, Jonathan Siff, Peter J. Greco, Edward Warren, J. Daryl Thornton & Yasir Tarabichi. (2022) The Impact of an Electronic Health Record Intervention on Spirometry Completion in Patients with Chronic Obstructive Pulmonary Disease. COPD: Journal of Chronic Obstructive Pulmonary Disease 19:1, pages 142-148.
Read now
Ashraf Al Zaabi, Nasser Busaidi, Saleh Al Mutairy, Arzu Yorgancıoğlu, Kurtuluş Aksu, Hamdan Al-Jahdali, Siraj Wali, Mohamed Elsayed & Maarten JHI Beekman. (2022) Overprescription of short-acting β2-agonists is associated with poor asthma symptom control: results from five Middle Eastern countries included in the SABINA International (III) study. Expert Review of Respiratory Medicine 16:7, pages 833-847.
Read now
Cassandra Nan, Olaf Schmidt, Robert Lindner, Yasemin Ilgin, Thomas Schultz, Lykke Hinsch Gylvin & Eugene R. Bleecker. (2022) German regional variation of acute and high oral corticosteroid use for asthma. Journal of Asthma 59:4, pages 791-800.
Read now
Ling Eng Tan, Wan Hui Gloria Tan, Mohamed Ismail Abdul Aziz, Mariko Siyue Koh, Tunn Ren Tay, Fiona Pearce & Kwong Ng. (2022) Assessing the cost-effectiveness of mepolizumab as add-on therapy to standard of care for severe eosinophilic asthma in Singapore. Journal of Asthma 59:1, pages 189-199.
Read now
Joseph W Lanario & Lorna Burns. (2021) Use of Health Related Quality of Life in Clinical Trials for Severe Asthma: A Systematic Review. Journal of Asthma and Allergy 14, pages 999-1010.
Read now
Trung N Tran, Marjan Kerkhof, Victoria Carter & David B Price. (2021) Persistence of Eosinophilic Asthma Endotype and Clinical Outcomes: A Real-World Observational Study. Journal of Asthma and Allergy 14, pages 727-742.
Read now
Francesco Menzella, Marco Bonavia, Matteo Bonini, Maria D’Amato, Salvatore Lombardo, Nicola Murgia, Vincenzo Patella, Massimo Triggiani & Girolamo Pelaia. (2021) Real-World Experience with Benralizumab in Patients with Severe Eosinophilic Asthma: A Case Series. Journal of Asthma and Allergy 14, pages 149-161.
Read now
Pierluigi Paggiaro, Simona Barbaglia, Stefano Centanni, Davide Croce, Enrico Desideri, Saffi Giustini, Claudio Micheletto, Antonino Musarra, Nicola Scichilone, Ugo Trama, Maria Teresa Zedda & Giorgio Walter Canonica. (2021) Overcoming Barriers to the Effective Management of Severe Asthma in Italy. Journal of Asthma and Allergy 14, pages 481-491.
Read now
Francesco Menzella, Giulia Ghidoni, Matteo Fontana, Silvia Capobelli, Francesco Livrieri, Claudia Castagnetti & Nicola Facciolongo. (2021) The role of systemic corticosteroids in severe asthma and new evidence in their management and tapering. Expert Review of Clinical Immunology 17:12, pages 1283-1299.
Read now
Quentin Delcros, Matthieu Groh, Mouhamad Nasser, Jean-Emmanuel Kahn & Vincent Cottin. (2021) Steroid alternatives for managing eosinophilic lung diseases. Expert Opinion on Orphan Drugs 9:7-10, pages 205-218.
Read now
David Ranford & Claire Hopkins. (2021) Safety review of current systemic treatments for severe chronic rhinosinusitis with nasal polyps and future directions. Expert Opinion on Drug Safety 20:10, pages 1177-1189.
Read now
Zhuo Fu, Yongsheng Xu & Chunquan Cai. (2021) Efficacy and safety of omalizumab in children with moderate-to-severe asthma: a meta-analysis. Journal of Asthma 58:10, pages 1350-1358.
Read now
Marc Humbert, Arnaud Bourdin, Nikolaos G. Papadopoulos, Stephen T. Holgate, Nicola A. Hanania, David M. G. Halpin, Kenneth R. Chapman, Marcela Gavornikova, David B. Price, Alan Kaplan & Liam G. Heaney. (2021) Reducing the hidden burden of severe asthma: recognition and referrals from primary practice. Journal of Asthma 58:7, pages 849-854.
Read now
Arnaud Bourdin, Dominick Shaw, Andrew Menzies-Gow, J. Mark FitzGerald, Eugene R. Bleecker, William W. Busse, Gary T. Ferguson, Laura Brooks, Peter Barker, Esther Garcia Gil & Ubaldo J. Martin. (2021) Two-year integrated steroid-sparing analysis and safety of benralizumab for severe asthma. Journal of Asthma 58:4, pages 514-522.
Read now
Georgia Papapostolou, Alf Tunsäter, Jonas Binnmyr, Gunilla Telg & Klaus Roslind. (2021) Patient perspectives on living with severe asthma in Denmark and Sweden. European Clinical Respiratory Journal 8:1.
Read now
Christopher S Ambrose, Bradley E Chipps, Wendy C Moore, Weily Soong, Jennifer Trevor, Dennis K Ledford, Warner W Carr, Njira Lugogo, Frank Trudo, Trung N Tran & Reynold A Panettieri$suffix/text()$suffix/text(). (2020) The CHRONICLE Study of US Adults with Subspecialist-Treated Severe Asthma: Objectives, Design, and Initial Results. Pragmatic and Observational Research 11, pages 77-90.
Read now
Jared Silver, Michael Bogart, Elizabeth Packnett, Juan Wu, Donna McMorrow & Beth Hahn. (2020) Real-World Reductions in Oral Corticosteroid Use in the USA Following Mepolizumab Therapy for Severe Asthma. Journal of Asthma and Allergy 13, pages 689-699.
Read now
Alan Kaplan & David Price. (2020) Treatment Adherence in Adolescents with Asthma. Journal of Asthma and Allergy 13, pages 39-49.
Read now
Stephanie Chen, Anna Zhou, Benjamin Emmanuel, Kim Thomas & Hannah Guiang. (2020) Systematic literature review of the epidemiology and clinical burden of chronic rhinosinusitis with nasal polyposis. Current Medical Research and Opinion 36:11, pages 1897-1911.
Read now
Maria Andersson, Christer Janson, Thomas Kristensen, Agota Szende & Sarowar Golam. (2020) Cost effectiveness of benralizumab for severe, uncontrolled oral corticosteroid–dependent asthma in Sweden. Journal of Medical Economics 23:8, pages 877-884.
Read now
Olivia M. Whalen, Linda E. Campbell, Vanessa E. Murphy, Alison E. Lane, Peter G. Gibson, Joerg Mattes, Adam Collison, Carly A. Mallise, Alix Woolard & Frini Karayanidis. (2020) Observational study of mental health in asthmatic women during the prenatal and postnatal periods. Journal of Asthma 57:8, pages 829-841.
Read now
Francesco Menzella, Manuela Latorre, Patrizia Ruggiero, Diego Bagnasco & Enrico Heffler. (2019) Reduction of oral corticosteroids in patients with severe eosinophilic asthma treated with Benralizumab: could it represent a marker of treatment efficacy?. Expert Opinion on Biological Therapy 19:7, pages 601-606.
Read now

Articles from other publishers (165)

Heath Heatley, Trung N Tran, Arnaud Bourdin, Andrew Menzies-Gow, David J Jackson, Ekaterina Maslova, Jatin Chapaneri, Derek Skinner, Victoria Carter, Jeffrey Shi Kai Chan, Con Ariti, John Haughney & David B Price. (2023) Observational UK cohort study to describe intermittent oral corticosteroid prescribing patterns and their association with adverse outcomes in asthma. Thorax 78:9, pages 860-867.
Crossref
Paul E. Pfeffer, Nasloon Ali, Ruth Murray, Charlotte Ulrik, Trung N. Tran, Jorge Maspero, Matthew Peters, George C. Christoff, Mohsen Sadatsafavi, Carlos A. Torres‐Duque, Alan Altraja, Lauri Lehtimäki, Nikolaos G. Papadopoulos, Sundeep Salvi, Richard W. Costello, Breda Cushen, Enrico Heffler, Takashi Iwanaga, Mona Al‐Ahmad, Désirée Larenas‐Linnemann, Piotr Kuna, João A. Fonseca, Riyad Al‐Lehebi, Chin Kook Rhee, Luis Perez‐de‐Llano, Diahn‐Warng Perng Steve, Bassam Mahboub, Eileen Wang, Celine Goh, Juntao Lyu, Anthony Newell, Marianna Alacqua, Andrey S. Belevskiy, Mohit Bhutani, Leif Bjermer, Unnur Bjornsdottir, Arnaud Bourdin, Anna von Bulow, John Busby, Giorgio Walter Canonica, Borja G. Cosio, Delbert R. Dorscheid, Mariana Muñoz‐Esquerre, J. Mark FitzGerald, Esther Garcia Gil, Peter G. Gibson, Liam G. Heaney, Mark Hew, Ole Hilberg, Flavia Hoyte, David J. Jackson, Mariko Siyue Koh, Hsin‐Kuo Bruce Ko, Jae Ha Lee, Sverre Lehmann, Cláudia Chaves Loureiro, Dóra Lúðvíksdóttir, Andrew N. Menzies‐Gow, Patrick Mitchell, Andriana I. Papaioannou, Todor A. Popov, Celeste M. Porsbjerg, Laila Salameh, Concetta Sirena, Camille Taillé, Christian Taube, Yuji Tohda, Michael E. Wechsler & David B. Price. (2023) Comparative effectiveness of anti‐IL5 and anti‐IgE biologic classes in patients with severe asthma eligible for both . Allergy 78:7, pages 1934-1948.
Crossref
Luke E. Barry, Ciaran O’Neill, Claire Butler, Rekha Chaudhuri & Liam G. Heaney. (2023) Cost-Effectiveness of Fractional Exhaled Nitric Oxide Suppression Testing as an Adherence Screening Tool Among Patients With Difficult-to-Control Asthma. The Journal of Allergy and Clinical Immunology: In Practice 11:6, pages 1796-1804.e3.
Crossref
Katarzyna Wójcik-Pszczoła, Krzysztof Pociecha, Grażyna Chłoń-Rzepa, Monika Zadrożna, Barbara Nowak, Hanna Plutecka, Paulina Koczurkiewicz-Adamczyk, Katarzyna Przejczowska-Pomierny, Elżbieta Pękala, Reinoud Gosens & Elżbieta Wyska. (2023) Inhaled pan-phosphodiesterase inhibitors ameliorate ovalbumin-induced airway inflammation and remodeling in murine model of allergic asthma. International Immunopharmacology 119, pages 110264.
Crossref
John Haughney, Tonya Winders, Steve Holmes, Pascal Chanez, Andrew Menzies-Gow, Janwillem Kocks, Adel H. Mansur, Christopher McPherson & Giorgio Walter Canonica. (2023) A Charter to Fundamentally Change the Role of Oral Corticosteroids in the Management of Asthma. Advances in Therapy 40:6, pages 2577-2594.
Crossref
Alessandra Vultaggio, Maria Aliani, Elena Altieri, Pietro Bracciale, Luisa Brussino, Maria Filomena Caiaffa, Paolo Cameli, Giorgio Walter Canonica, Cristiano Caruso, Stefano Centanni, Maria D’Amato, Fausto De Michele, Stefano Del Giacco, Fabiano Di Marco, Francesco Menzella, Girolamo Pelaia, Paola Rogliani, Micaela Romagnoli, Pietro Schino, Gianenrico Senna, Marco Benci, Silvia Boarino & Jan Walter Schroeder. (2023) Long-term effectiveness of benralizumab in severe eosinophilic asthma patients treated for 96-weeks: data from the ANANKE study. Respiratory Research 24:1.
Crossref
Emanuele Nappi, Enrico Keber, Giovanni Paoletti, Marta Casini, Carolina Carosio, Flora Romano, Nicolina Floris, Claudio Parmigiani, Carlo Salvioni, Luca Malvezzi, Francesca Puggioni, Giorgio Walter Canonica, Enrico Heffler & Corrado Giua. (2023) Oral Corticosteroid Abuse and Self-Prescription in Italy: A Perspective from Community Pharmacists and Sales Reports before and during the COVID-19 Era. Journal of Personalized Medicine 13:5, pages 833.
Crossref
Christian Domingo, Ana Sogo, Enrique Casado, Eva Martínez-Moragón, Marina Blanco-Aparicio, Teresa Carrillo, David Bañas-Conejero & María-Guadalupe Sánchez-Herrero. (2023) Potential impact of mepolizumab in stepping down anti-osteporotic treatment in corticosteroid-dependent asthma. Frontiers in Pharmacology 14.
Crossref
Edward D. McCoul, Uchechukwu C. Megwalu, Stephanie Joe, Raluca Gray, Daniel C. O'Brien, Elisabeth H. Ference, Victoria S. Lee, Prayag S. Patel, Marco A. Figueroa‐Morales, Jennifer J. Shin & Michael J. Brenner. (2022) Systemic Steroids for Otolaryngology–Head and Neck Surgery Disorders: An Evidence‐Based Primer for Clinicians. Otolaryngology–Head and Neck Surgery 168:4, pages 643-657.
Crossref
Katrin MilgerStephanie Korn, Claudia Feder, Jan Fuge, Andreas Mühle, Wolfgang Schütte, Dirk Skowasch, Hartmut Timmermann & Hendrik Suhling. (2023) Kriterien zur Evaluation des Ansprechens auf Biologika bei schwerem Asthma – der Biologics Asthma Response Score (BARS). Pneumologie 77:04, pages 220-232.
Crossref
Jorge F. Maspero, Alvaro A. Cruz, Cesar Fireth Pozo Beltran, Abraham Ali Munive, Felicia Montero-Arias, Ramses Hernandez Pliego & Hisham Farouk. (2023) The use of systemic corticosteroids in asthma management in Latin American countries. World Allergy Organization Journal 16:4, pages 100760.
Crossref
Matthew C. Eastwood, John Busby, David J. Jackson, Ian D. Pavord, Catherine E. Hanratty, Ratko Djukanovic, Ashley Woodcock, Samantha Walker, Timothy C. Hardman, Joseph R. Arron, David F. Choy, Peter Bradding, Chris E. Brightling, Rekha Chaudhuri, Douglas Cowan, Adel H. Mansur, Stephen J. Fowler, Peter Howarth, James Lordan, Andrew Menzies-Gow, Timothy Harrison, Douglas S. Robinson, Cecile T.J. Holweg, John G. Matthews & Liam G. Heaney. (2023) A Randomized Trial of a Composite T2-Biomarker Strategy Adjusting Corticosteroid Treatment in Severe Asthma: A Post Hoc Analysis by Sex. The Journal of Allergy and Clinical Immunology: In Practice 11:4, pages 1233-1242.e5.
Crossref
Akio Niimi, Koichi Fukunaga, Masami Taniguchi, Yoichi Nakamura, Etsuko Tagaya, Takahiko Horiguchi, Akihito Yokoyama, Masao Yamaguchi & Makoto Nagata. (2023) Executive summary: Japanese guidelines for adult asthma (JGL) 2021. Allergology International 72:2, pages 207-226.
Crossref
Eleanor Roberts. (2023) Oral Corticosteroids for Patients with Eosinophilic Diseases: An Expert Panel View on Use, Overuse, and Strategies to Reduce Use. European Medical Journal, pages 69-79.
Crossref
John Haughney, Trung N. Tran, Heath Heatley, Arnaud Bourdin, Andrew Menzies-Gow, David J. Jackson, Ekaterina Maslova, Jatin Chapaneri, Derek Skinner, Victoria Carter, Jeffrey Shi Kai Chan & David Price. (2023) Application of an algorithm to analyze patterns of intermittent oral corticosteroid use in asthma. npj Primary Care Respiratory Medicine 33:1.
Crossref
Tae Yoon Lee, Mohsen Sadatsafavi, Chandra Prakash Yadav, David B Price, Richard Beasley, Christer Janson, Mariko Siyue Koh, Rupsa Roy & Wenjia Chen. (2023) Individualised risk prediction model for exacerbations in patients with severe asthma: protocol for a multicentre real-world risk modelling study. BMJ Open 13:3, pages e070459.
Crossref
Simon Couillard, Nayia Petousi, Kate S. Smigiel & Nestor A. Molfino. (2023) Toward a Predict and Prevent Approach in Obstructive Airway Diseases. The Journal of Allergy and Clinical Immunology: In Practice 11:3, pages 704-712.
Crossref
Lawrence D. Sher, Giovanni Passalacqua, Camille Taillé, Lauren Cohn, Nadia Daizadeh, Nami Pandit-Abid, Xavier Soler, Angela Khodzhayev, Juby A. Jacob-Nara, Yamo Deniz, Paul J. Rowe, Arpita Nag & Yi Zhang. (2023) The long-term effect of dupilumab on dyspnea, sleep, and activity in oral corticosteroid-dependent severe asthma. Annals of Allergy, Asthma & Immunology 130:3, pages 298-304.
Crossref
Abdullah A. Alqarni, Abdulelah M. Aldhahir, Rayan A. Siraj, Jaber S. Alqahtani, Hams H. Alshehri, Amal M. Alshamrani, Ahlam A. Namnqani, Lama N. Alsaidalani, Mohammed N. Tawhari, Omaima I. Badr & Hassan Alwafi. (2023) Prevalence of Overweight and Obesity and Their Impact on Spirometry Parameters in Patients with Asthma: A Multicentre, Retrospective Study. Journal of Clinical Medicine 12:5, pages 1843.
Crossref
Zenghui Jing, Xingzhi Wang, Panpan Zhang, Jinli Huang, Yuanyuan Jia, Juan Zhang, Huajie Wu & Xin Sun. (2023) Effects of physical activity on lung function and quality of life in asthmatic children: An updated systematic review and meta-analysis. Frontiers in Pediatrics 11.
Crossref
Mark L. Levy, Leonard B. Bacharier, Eric Bateman, Louis-Philippe Boulet, Chris Brightling, Roland Buhl, Guy Brusselle, Alvaro A. Cruz, Jeffrey M. Drazen, Liesbeth Duijts, Louise Fleming, Hiromasa Inoue, Fanny W. S. Ko, Jerry A. Krishnan, Kevin Mortimer, Paulo M. Pitrez, Aziz Sheikh, Arzu Yorgancıoğlu & Helen K. Reddel. (2023) Key recommendations for primary care from the 2022 Global Initiative for Asthma (GINA) update. npj Primary Care Respiratory Medicine 33:1.
Crossref
Marta Espada-Sánchez, Rocío Sáenz de Santa María, María del Carmen Martín-Astorga, Clara Lebrón-Martín, María Jesús Delgado, Ibón Eguiluz-Gracia, Carmen Rondón, Cristobalina Mayorga, María José Torres, Carlos José Aranda & José Antonio Cañas. (2023) Diagnosis and Treatment in Asthma and Allergic Rhinitis: Past, Present, and Future. Applied Sciences 13:3, pages 1273.
Crossref
Carlos Almonacid, Eunice Fitas, Joaquín Sánchez-Covisa, Héctor Gutiérrez & Pablo Rebollo. (2023) Geographical differences in the use of oral corticosteroids in patients with severe asthma in Spain: heat map based on existing databases analyses. BMC Pulmonary Medicine 23:1.
Crossref
Robert Naclerio, Joaquim Mullol & Whitney W. Stevens. (2023) A Decade of Clinical Advances in Chronic Rhinosinusitis: 2012–2022. The Journal of Allergy and Clinical Immunology: In Practice 11:1, pages 43-50.
Crossref
Kelly Barta, Luz S. Fonacier, Mary Hart, Peter Lio, Kathryn Tullos, Belinda Sheary & Tonya A. Winders. (2023) Corticosteroid exposure and cumulative effects in patients with eczema. Annals of Allergy, Asthma & Immunology 130:1, pages 93-99.e10.
Crossref
Koichiro Asano, Yuzo Suzuki, Jun Tanaka, Konomi Kobayashi & Yosuke Kamide. (2023) Treatments of refractory eosinophilic lung diseases with biologics. Allergology International 72:1, pages 31-40.
Crossref
Ji-Sun Paik, Kyungdo Han, Gahee Nam, Sun-Kyoung Park, Ho Sik Hwang, Yoon Hong Chun & Kyung-Sun Na. (2022) Increased risk of cataract surgery in patients with allergic disease: a population based cohort study. Scientific Reports 12:1.
Crossref
Kazuya Takeda, Toshiyuki Sumi, Yuta Nagahisa, Keigo Matsuura, Motoki Sekikawa, Hiroki Watanabe, Yuichi Yamada & Hirofumi Chiba. (2022) Refractory flare-up of severe bronchial asthma controlled with mepolizumab due to Pneumocystis pneumonia: a case report. Allergy, Asthma & Clinical Immunology 18:1.
Crossref
David Price & Thendral Uthaman. (2022) What have we learnt from real‐life research in asthma and COPD ? Standards and novel designs for the future . Respirology 27:12, pages 1018-1021.
Crossref
Eugene R. Bleecker, Mona Al-Ahmad, Leif Bjermer, Marco Caminati, Giorgio Walter Canonica, Alan Kaplan, Nikolaos G. Papadopoulos, Nicolas Roche, Dermot Ryan, Yuji Tohda, Anahí Yáñez & David Price. (2022) Systemic corticosteroids in asthma: A call to action from World Allergy Organization and Respiratory Effectiveness Group. World Allergy Organization Journal 15:12, pages 100726.
Crossref
Andrew Menzies-Gow, David J. Jackson, Mona Al-Ahmad, Eugene R. Bleecker, Francisco de Borja G. Cosio Piqueras, Stephen Brunton, Giorgio Walter Canonica, Charles K. N. Chan, John Haughney, Steve Holmes, Janwillem Kocks & Tonya Winders. (2022) A Renewed Charter: Key Principles to Improve Patient Care in Severe Asthma. Advances in Therapy 39:12, pages 5307-5326.
Crossref
David Price & Arnaud Bourdin. (2022) Proactive Risk Management: A Novel Approach to Embedding Oral Corticosteroid Stewardship into Asthma Care. EMJ Respiratory.
Crossref
William W. Busse. (2022) Improving systemic corticosteroid stewardship in asthma. European Respiratory Journal 60:5, pages 2201440.
Crossref
Kevin MortimerRefiloe MasekelaObianuju B OzohEric Donn BatemanRebecca NantandaArzu A. YorgancıoğluJeremiah ChakayaHelen K. Reddel. (2022) The reality of managing asthma in sub-Saharan Africa – Priorities and strategies for improving care. Journal of the Pan African Thoracic Society 3, pages 105-120.
Crossref
Javier Domínguez-Ortega, Julio Delgado Romero, Xavier Muñoz Gall, Amparo Marco & Marina Blanco-Aparicio. (2022) Uso de glucocorticoides sistémicos para el tratamiento del asma grave: Consenso multidisciplinar español. Open Respiratory Archives 4:4, pages 100202.
Crossref
Charles Pilette, Giorgio Walter Canonica, Rekha Chaudhuri, Geoffrey Chupp, F. Eun-Hyung Lee, Jason Kihyuk Lee, Carlos Almonacid, Tobias Welte, Rafael Alfonso-Cristancho, Rupert W. Jakes, Aoife Maxwell, Robert G. Price & Peter Howarth. (2022) REALITI-A Study: Real-World Oral Corticosteroid-Sparing Effect of Mepolizumab in Severe Asthma. The Journal of Allergy and Clinical Immunology: In Practice 10:10, pages 2646-2656.
Crossref
Dermot Ryan, Luciana K. Tanno, Elizabeth Angier, Evangéline Clark, David Price, Torsten Zuberbier & Marcus Maurer. (2022) Clinical review: The suggested management pathway for urticaria in primary care. Clinical and Translational Allergy 12:10.
Crossref
Wen Yan Huang, Sang Hoon Lee, Seong Ju Oh, Hyeock Yoon, Jeong Hoon Pan, Inhye Jeong, Mi Jeong Kim, Bok Kyung Han, Jae Kyeom Kim, Eui-Cheol Shin & Young Jun Kim. (2022) Canavalia gladiata Pod Extract Mitigates Ovalbumin-Induced Asthma Onset in Male BALB/c Mice via Suppression of MAPK. Molecules 27:19, pages 6317.
Crossref
Kevin Mortimer, Helen K. Reddel, Paulo M. Pitrez & Eric D. Bateman. (2022) Asthma management in low and middle income countries: case for change. European Respiratory Journal 60:3, pages 2103179.
Crossref
Inge Raadal Skov, Hanne Madsen, Daniel Pilsgaard Henriksen, Jacob Harbo Andersen, Anton Pottegård & Jesper Rømhild Davidsen. (2022) Low-dose oral corticosteroids in asthma associates with increased morbidity and mortality. European Respiratory Journal 60:3, pages 2103054.
Crossref
Jeffrey Shi Kai Chan, Ruth B. Murray & David Price. (2022) Oral corticosteroids in asthma and beyond: moving forward. European Respiratory Journal 60:3, pages 2200776.
Crossref
David M. Lang. (2022) Chronic Urticaria. New England Journal of Medicine 387:9, pages 824-831.
Crossref
Greg E. Davis, Robert S. Zeiger, Benjamin Emmanuel, Yen Chung, Trung N. Tran, Kristin A. Evans, Stephanie Chen, Rohit Katial, James L. Kreindler & Joseph Tkacz. (2022) Systemic Corticosteroid–related Adverse Outcomes and Health Care Resource Utilization and Costs Among Patients with Chronic Rhinosinusitis with Nasal Polyposis. Clinical Therapeutics 44:9, pages 1187-1202.
Crossref
Sarowar Muhammad Golam, Christer Janson, Richard Beasley, J Mark FitzGerald, Tim Harrison, Bradley Chipps, Rod Hughes, Hana Müllerová, José María Olaguibel, Eleni Rapsomaniki, Helen K. Reddel, Mohsen Sadatsafavi, Gabriel Benhabib, Piushkumar Mandhane, Xavier Bocca Ruiz, Andrew McIvor, Ricardo del Olmo, Bonavuth Pek, Raul Eduardo Lisanti, Robert Petrella, Gustavo Marino, Daniel Stollery, Walter Mattarucco, Meihua Chen, Juan Nogueira, Yan Chen, Maria Parody, Wei Gu, Pablo Pascale, Kim Ming Christopher Hui, Pablo Rodriguez, Manxiang Li, Damian Silva, Shiyue Li, Graciela Svetliza, Lijun Ma, Carlos F. Victorio, Guangyue Qin, Roxana Willigs Rolon, Weidong Song, Anahi Yañez, Wei Tan, Stuart Baines, Yijun Tang, Simon Bowler, Chen Wang, Peter Bremner, Tan Wang, Sheetal Bull, Fuqiang Wen, Patrick Carroll, Feng Wu, Mariam Chaalan, PingChao Xiang, Claude Farah, Zuke Xiao, Gary Hammerschlag, Shengdao Xiong, Kerry Hancock, Jinghua Yang, Zinta Harrington, Jingping Yang, Gregory Katsoulotos, Caiqing Zhang, Joshua Kim, Min Zhang, David Langton, Ping Zhang, Donald Lee, Wei Zhang, Matthew Peters, Xiaohe Zheng, Lakshman Prassad, Dan Zhu, Helen Reddel, Fabio Bolivar Grimaldos, Dimitar Sajkov, Alejandra Cañas Arboleda, Francis Santiago, Carlos Matiz Bueno, Frederick Graham Simpson, Dora Molina de Salazar, Sze Tai, Elisabeth Bendstrup, Paul Thomas, Ole Hilberg, Peter Wark, Carsten Kjellerup, José Eduardo Delfini Cançado, Ulla Weinreich, Thúlio Cunha, Philippe Bonniaud, Marina Lima, Olivier Brun, Alexandre Pinto Cardoso, Pierre-Régis Burgel, Marcelo Rabahi, Christos Chouaid, Syed Anees, Francis Couturaud, John Bertley, Jacques de Blic, Alan Bell, Didier Debieuvre, Amarjit Cheema, Dominique Delsart, Guy Chouinard, Axelle Demaegdt, Michael Csanadi, Pascal Demoly, Anil Dhar, Antoine Deschildre, Ripple Dhillon, Gilles Devouassoux, J. Mark FitzGerald, Carole Egron, David Kanawaty, Lionel Falchero, Allan Kelly, François Goupil, William Killorn, Romain Kessler, Daniel Landry, Pascal Le Roux, Robert Luton, Pascal Mabire, Guillaume Mahay, Yumiko Ide, Stéphanie Martinez, Minehiko Inomata, Boris Melloni, Hiromasa Inoue, Laurent Moreau, Koji Inoue, Chantal Raherison, Sumito Inoue, Emilie Riviere, Motokazu Kato, Pauline Roux-Claudé, Masayuki Kawasaki, Michel Soulier, Tomotaka Kawayama, Guillaume Vignal, Toshiyuki Kita, Azzedine Yaici, Kanako Kobayashi, Sven Philip Aries, Hiroshi Koto, Robert Bals, Koichi Nishi, Ekkehard Beck, Junpei Saito, Andreas Deimling, Yasuo Shimizu, Jan Feimer, Toshihiro Shirai, Vera Grimm-Sachs, Naruhiko Sugihara, Gesine Groth, Ken-ichi Takahashi, Felix Herth, Hiroyuki Tashimo, Gerhard Hoheisel, Keisuke Tomii, Frank Kanniess, Takashi Yamada, Thomas Lienert, Masaru Yanai, Silke Mronga, Ruth Cerino Javier, Jörg Reinhardt, Alfredo Domínguez Peregrina, Christian Schlenska, Marco Fernández Corzo, Christoph Stolpe, Efraín Montano Gonzalez, Ishak Teber, Alejandra Ramírez-Venegas, Hartmut Timmermann, Adrian Rendon, Thomas Ulrich, Willem Boersma, Peter Velling, R.S. Djamin, Sabina Wehgartner-Winkler, Michiel Eijsvogel, Juergen Welling, Frits Franssen, Ernst-Joachim Winkelmann, Martijn Goosens, Carlo Barbetta, Lidwien Graat-Verboom, Fulvio Braido, Johannes in 't Veen, Vittorio Cardaci, Rob Janssen, Enrico Maria Clini, Kim Kuppens, Maria Teresa Costantino, Maarten van den Berge, Giuseppina Cuttitta, Mario van de Ven, Mario di Gioacchino, Ole Petter Brunstad, Alessandro Fois, Gunnar Einvik, Maria Pia Foschino-Barbaro, Kristian Jong Høines, Enrico Gammeri, Alamdar Khusrawi, Riccardo Inchingolo, Torbjorn Oien, Federico Lavorini, Yoon-Seok Chang, Antonio Molino, Young Joo Cho, Eleonora Nucera, Yong Il Hwang, Alberto Papi, Woo Jin Kim, Vincenzo Patella, Young-Il Koh, Alberto Pesci, Byung-Jae Lee, Fabio Ricciardolo, Kwan-Ho Lee, Paola Rogliani, Sang-Pyo Lee, Riccardo Sarzani, Yong Chul Lee, Carlo Vancheri, Seong Yong Lim, Rigoletta Vincenti, Kyung Hun Min, Takeo Endo, Yeon-Mok Oh, Masaki Fujita, Choon-Sik Park, Yu Hara, Hae-Sim Park, Takahiko Horiguchi, Heung-Woo Park, Keita Hosoi, Chin Kook Rhee, Ho Joo Yoon, Alyn Morice, Hyoung-Kyu Yoon, Preeti Pandya, Alvar Agusti García-Navarro, Manish Patel, Rubén Andújar, Kay Roy, Laura Anoro, Ramamurthy Sathyamurthy, María Buendía García, Swaminathan Thiagarajan, Paloma Campo Mozo, Alice Turner, Sergio Campos, Jorgen Vestbo, Francisco Casas Maldonado, Wisia Wedzicha, Manuel Castilla Martínez, Tom Wilkinson, Carolina Cisneros Serrano, Pete Wilson, Lorena Comeche Casanova, Lo’Ay Al-Asadi, Dolores Corbacho, James Anholm, Felix Del Campo Matías, Frank Averill, Jose Echave-Sustaeta, Sandeep Bansal, Gloria Francisco Corral, Alan Baptist, Pedro Gamboa Setién, Colin Campbell, Marta García Clemente, Michael A. Campos, Ignacio García Núñez, Bradley Chipps, Jose García Robaina, Gretchen Crook, Mercedes García Salmones, Samuel DeLeon, Jose Maria Marín Trigo, Alain Eid, Marta Nuñez Fernandez, Ellen Epstein, Sara Nuñez Palomo, Stephen Fritz, José Olaguibel Rivera, Hoadley Harris, Luis Pérez de Llano, Mitzie Hewitt, Ana Pueyo Bastida, Fernando Holguin, Ana Rañó, Golda Hudes, José Rodríguez González-Moro, Richard Jackson, Albert Roger Reig, Alan Kaufman, José Velasco Garrido, David Kaufman, Dan Curiac, Ari Klapholz, Christer Janson, Harshavardhan Krishna, Cornelia Lif-Tiberg, Daria Lee, Anders Luts, Robert Lin, Lennart Råhlen, Diego Maselli-Caceres, Stefan Rustscheff, Vinay Mehta, Frances Adams, James N. Moy, Drew Bradman, Ugo Nwokoro, Emma Broughton, Purvi Parikh, John Cosgrove, Sudhir Parikh, Patrick Flood-Page, Frank Perrino, Elizabeth Fuller, James Ruhlmann, Timothy Harrison, Catherine Sassoon, David Hartley, Russell A. Settipane, Keith Hattotuwa, Daniel Sousa, Gareth Jones, Peruvemba Sriram, Keir Lewis, Richard Wachs & Lorcan McGarvey. (2022) The burden of mild asthma: Clinical burden and healthcare resource utilisation in the NOVELTY study. Respiratory Medicine 200, pages 106863.
Crossref
Akke-Nynke van der Meer, Kim de Jong, Michiel Ferns, Christine Widrich & Anneke ten Brinke. (2022) Overuse of Oral Corticosteroids in Asthma Is Often Underdiagnosed and Inadequately Addressed. The Journal of Allergy and Clinical Immunology: In Practice 10:8, pages 2093-2098.
Crossref
Inge Raadal Skov, Hanne Madsen, Jacob Harbo Andersen, Anton Pottegård & Jesper Rømhild Davidsen. (2022) Trends and predictors of specialist assessments in oral corticosteroid treated asthma among young adults. ERJ Open Research 8:3, pages 00142-2022.
Crossref
Francisco Javier Alvarez-Gutiérrez, Marina Blanco-Aparicio, Francisco Casas-Maldonado, Vicente Plaza, Francisco Javier González-Barcala, José Ángel Carretero-Gracia, Manuel Castilla-Martínez, Carolina Cisneros, David Diaz-Pérez, Christian Domingo-Ribas, Eva Martínez-Moragon, Xavier Muñoz, Alicia Padilla-Galo, Miguel Perpiñá-Tordera & Gregorio Soto-Campos. (2022) Documento de consenso de asma grave en adultos. Actualización 2022. Open Respiratory Archives 4:3, pages 100192.
Crossref
Christian Domingo, Jorge F. Maspero, Mario Castro, Nicola A. Hanania, Linda B. Ford, David M.G. Halpin, David J. Jackson, Nadia Daizadeh, Michel Djandji, Colin P. Mitchell, Nora Crikelair, Juby A. Jacob-Nara, Yamo Deniz, Paul J. Rowe & Benjamin Ortiz. (2022) Dupilumab Efficacy in Steroid-Dependent Severe Asthma by Baseline Oral Corticosteroid Dose. The Journal of Allergy and Clinical Immunology: In Practice 10:7, pages 1835-1843.
Crossref
Njira Lugogo & Arjun Mohan. (2022) Are We Poised to Change the Trajectory of Maintenance Oral Corticosteroid Use in Severe Asthma in the Age of Biologics?. Chest 162:1, pages 4-5.
Crossref
Michael E Wechsler, Andrew Menzies-Gow, Christopher E Brightling, Piotr Kuna, Stephanie Korn, Tobias Welte, Janet M Griffiths, Kinga Sałapa, Åsa Hellqvist, Gun Almqvist, Harbans Lal, Primal Kaur, Tor Skärby, Gene Colice, Victor H Cambursano, Marcelo J Fernandez, Fernando D Scherbovsky, Anahi Yanez, Alberto J Tolcachier, Ana M Stok, Fernando J B Verra, Stephanie Korn, Karin Forster, Mathias Rolke, Andrea Ludwig-Sengpiel, Tibor Schmoller, Olaf Schmidt, Katrin Milger-Kneidinger, Martin Hoffmann, Hilke Temme, Anneliese Linnhoff, Tobias Welte, Joachim Kirschner, Piotr Kuna, Barbara Rewerska, Ewa Pisarczyk-Bogacka, Sang Haak Lee, Byung Jae Lee, Heung-Woo Park, Jung-Won Park, Sook Young Lee, You Sook Cho, Kwan Ho Lee, Sevim Bavbek, Bilun Gemicioglu, Dane Ediger, Ilkay Koca Kalkan, Ismail Hanta, Arzu Yorgancioglu, Yevgeniya DytyatkovsKa, Yuriy M Mostovoy, Kyrylo Lebed, Oleh Yakovenko, David I Bernstein, Jeffrey P Tillinghast, Loretta Que, Jan Madison, Todd Rambasek, Kartik Shenoy, Charles A Thompson, Christopher M Chappel, Golda Hudes, Ehab Sorial, Shahrukh A Kureishy, Syed M Rehman, Njira Lugogo, Erika G Gonzalez, Fred C Umeh, Eric J Boren, Jason Sigmon, Hummayun Ismail, Arjun Mohan, Sandeep Bansal & Thomas D Kaelin. (2022) Evaluation of the oral corticosteroid-sparing effect of tezepelumab in adults with oral corticosteroid-dependent asthma (SOURCE): a randomised, placebo-controlled, phase 3 study. The Lancet Respiratory Medicine 10:7, pages 650-660.
Crossref
Giovanni Paoletti, Jack Pepys, Marta Casini, Danilo Di Bona, Enrico Heffler, Celine Y.Y. Goh, David B. Price & Giorgio Walter Canonica. (2022) Biologics in severe asthma: the role of real-world evidence from registries. European Respiratory Review 31:164, pages 210278.
Crossref
Mehmet Erdem Çakmak, Saltuk Buğra Kaya, Özge Can Bostan, Ebru Damadoğlu, Gül Karakaya & Ali Fuat Kalyoncu. (2022) Short- and long-term oral steroid therapy in patients with asthma exacerbation. Monaldi Archives for Chest Disease.
Crossref
Dennis Thomas, Vanessa M. McDonald, Jodie L. Simpson, Amber Smith, Sachin Gupta, Eleanor Majellano & Peter G. Gibson. (2022) Patterns of azithromycin use in obstructive airway diseases: a real‐world observational study. Internal Medicine Journal 52:6, pages 1016-1023.
Crossref
Cecelia Damask. (2022) AERD: Current Roles for Aspirin Desensitization, Surgery, and Biologic Therapies. Current Otorhinolaryngology Reports 10:2, pages 179-187.
Crossref
David J. Jackson, Praveen Akuthota, Rebeca Andradas, Albert J. Bredenoord, Amanda Cordell, Sarah Gray, Joyce Kullman, Sameer K. Mathur, Ian Pavord, Florence Roufosse, Christian Rubio, Irena Clisson Rusek, Dagmar Simon, Mary Jo Strobel & Tonya Winders. (2022) Improving Care in Eosinophil-Associated Diseases: A Charter. Advances in Therapy 39:6, pages 2323-2341.
Crossref
Maria D'Amato, Francesco Menzella, Elena Altieri, Elena Bargagli, Pietro Bracciale, Luisa Brussino, Maria Filomena Caiaffa, Giorgio Walter Canonica, Cristiano Caruso, Stefano Centanni, Fausto De Michele, Fabiano Di Marco, Elide Anna Pastorello, Girolamo Pelaia, Paola Rogliani, Micaela Romagnoli, Pietro Schino, Gianenrico Senna, Alessandra Vultaggio, Alessandra Ori, Lucia Simoni, Silvia Boarino, Gianfranco Vitiello, Maria Aliani & Stefano Del Giacco. (2022) Benralizumab in Patients With Severe Eosinophilic Asthma With and Without Chronic Rhinosinusitis With Nasal Polyps: An ANANKE Study post-hoc Analysis. Frontiers in Allergy 3.
Crossref
Steve Turner, Seonaidh Cotton, Jessica Wood, Victoria Bell, Edwin-Amalraj Raja, Neil W Scott, Heather Morgan, Louisa Lawrie, David Emele, Charlotte Kennedy, Graham Scotland, Shona Fielding, Graeme MacLennan, John Norrie, Mark Forrest, Erol Gaillard, Johan de Jongeste, Marielle Pijnenburg, Mike Thomas & David Price. (2022) Treatment guided by fractional exhaled nitric oxide in addition to standard care in 6- to 15-year-olds with asthma: the RAACENO RCT. Efficacy and Mechanism Evaluation 9:4, pages 1-154.
Crossref
G. Jébrak, V. Houdouin, P. Terrioux, N. Lambert, B. Maitre & A.-M. Ruppert. (2022) Observance thérapeutique dans l’asthme : variation selon les classes d’âge. Comment l’améliorer ? Apport des nouvelles technologies. Revue des Maladies Respiratoires 39:5, pages 442-454.
Crossref
Andrew Menzies-Gow, Flavia L. Hoyte, David B. Price, David Cohen, Peter Barker, James Kreindler, Maria Jison, Christopher L. Brooks, Peggy Papeleu & Rohit Katial. (2022) Clinical Remission in Severe Asthma: A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab. Advances in Therapy 39:5, pages 2065-2084.
Crossref
Jas Bindra, Ishveen Chopra, Kyle Hayes, John Niewoehner, Mary P. Panaccio & George J. Wan. (2022) Understanding Predictors of Response to Repository Corticotropin Injection Treatment Among Patients With Advanced Symptomatic Sarcoidosis. Journal of Health Economics and Outcomes Research 9:1, pages 90-100.
Crossref
John Busby, John G. Matthews, Rekha Chaudhuri, Ian D. Pavord, Timothy C. Hardman, Joseph R. Arron, Peter Bradding, Christopher E. Brightling, David F. Choy, Douglas C. Cowan, Ratko Djukanovic, Catherine E. Hanratty, Tim W. Harrison, Cecile T. Holweg, Peter H. Howarth, Stephen J. Fowler, James L. Lordan, Adel H. Mansur, Andrew Menzies-Gow, Robert M. Niven, Douglas S. Robinson, Samantha M. Walker, Ashley Woodcock & Liam G. Heaney. (2022) Factors affecting adherence with treatment advice in a clinical trial of patients with severe asthma. European Respiratory Journal 59:4, pages 2100768.
Crossref
David J. Jackson, Praveen Akuthota & Florence Roufosse. (2022) Eosinophils and eosinophilic immune dysfunction in health and disease. European Respiratory Review 31:163, pages 210150.
Crossref
Petros Bakakos, Konstantinos Kostikas, Stelios Loukides, Michael Makris, Nikolaos G. Papadopoulos, Paschalis Steiropoulos, Stavros Tryfon & Eleftherios Zervas. (2022) Reducing Tolerance for SABA and OCS towards the Extreme Ends of Asthma Severity. Journal of Personalized Medicine 12:3, pages 504.
Crossref
Francesco Menzella, Elena Bargagli, Maria Aliani, Pietro Bracciale, Luisa Brussino, Maria Filomena Caiaffa, Cristiano Caruso, Stefano Centanni, Maria D’Amato, Stefano Del Giacco, Fausto De Michele, Fabiano Di Marco, Elide Anna Pastorello, Girolamo Pelaia, Paola Rogliani, Micaela Romagnoli, Pietro Schino, Gianenrico Senna, Alessandra Vultaggio, Lucia Simoni, Alessandra Ori, Silvia Boarino, Gianfranco Vitiello, Elena Altieri & Giorgio Walter Canonica. (2022) ChAracterization of ItaliaN severe uncontrolled Asthmatic patieNts Key features when receiving Benralizumab in a real-life setting: the observational rEtrospective ANANKE study. Respiratory Research 23:1.
Crossref
Eusebi Chiner, Carme Hernández, Marina Blanco‐Aparicio, Eunice Funenga‐Fitas & Carlos Jiménez‐Ruiz. (2021) Patient perspectives of the influence of severe and non‐severe asthma on their quality of life: A national survey of asthma patients in Spain. The Clinical Respiratory Journal 16:2, pages 130-141.
Crossref
Serafeim Chrysovalantis Kotoulas, Ioanna Tsiouprou, Eva Fouka, Athanasia Pataka, Despoina Papakosta & Konstantinos Porpodis. (2022) Omalizumab: An Optimal Choice for Patients with Severe Allergic Asthma. Journal of Personalized Medicine 12:2, pages 165.
Crossref
Maria Lawhorne & Ricky Kortyna. (2022) Osteonecrosis. JBJS Journal of Orthopaedics for Physician Assistants 10:4, pages e22.00014.
Crossref
Hitasha Rupani, Jessica Gates, Joanne E. Kavanagh & David J. Jackson. 2022. Eosinophilic Lung Diseases. Eosinophilic Lung Diseases 73 99 .
Helen K. Reddel, Leonard B. Bacharier, Eric D. Bateman, Christopher E. Brightling, Guy G. Brusselle, Roland Buhl, Alvaro A. Cruz, Liesbeth Duijts, Jeffrey M. Drazen, J. Mark FitzGerald, Louise J. Fleming, Hiromasa Inoue, Fanny W. Ko, Jerry A. Krishnan, Mark L. Levy, Jiangtao Lin, Kevin Mortimer, Paulo M. Pitrez, Aziz Sheikh, Arzu A. Yorgancioglu & Louis-Philippe Boulet. (2022) Global Initiative for Asthma Strategy 2021: executive summary and rationale for key changes. European Respiratory Journal 59:1, pages 2102730.
Crossref
Thomas B. Casale, Autumn Burnette, Arnaud Bourdin, Peter Howarth, Beth Hahn, Alexandra Stach-Klysh & Sandhya Khurana. (2022) Oral corticosteroid-sparing effects of mepolizumab in severe eosinophilic asthma: evidence from randomized controlled trials and real-world studies. Therapeutic Advances in Respiratory Disease 16, pages 175346662211073.
Crossref
Helen K. Reddel, Leonard B. Bacharier, Eric D. Bateman, Christopher E. Brightling, Guy G. Brusselle, Roland BuhlAlvaro A. CruzLiesbeth Duijts, Jeffrey M. Drazen, J. Mark FitzGerald, Louise J. Fleming, Hiromasa Inoue, Fanny W. Ko, Jerry A. Krishnan, Mark L. Levy, Jiangtao Lin, Kevin Mortimer, Paulo M. Pitrez, Aziz Sheikh, Arzu A. Yorgancioglu & Louis-Philippe Boulet. (2022) Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes. American Journal of Respiratory and Critical Care Medicine 205:1, pages 17-35.
Crossref
Katrien Eger, Marijke Amelink, Simone Hashimoto, Pieter-Paul Hekking, Cristina Longo & Elisabeth H. Bel. (2022) Overuse of Oral Corticosteroids, Underuse of Inhaled Corticosteroids, and Implications for Biologic Therapy in Asthma. Respiration 101:2, pages 116-121.
Crossref
Helen K. Reddel, Leonard B. Bacharier, Eric D. Bateman, Christopher E. Brightling, Guy G. Brusselle, Roland Buhl, Alvaro A. Cruz, Liesbeth Duijts, Jeffrey M. Drazen, J. Mark FitzGerald, Louise J. Fleming, Hiromasa Inoue, Fanny W. Ko, Jerry A. Krishnan, Mark L. Levy, Jiangtao Lin, Kevin Mortimer, Paulo M. Pitrez, Aziz Sheikh, Arzu A. Yorgancioglu & Louis‐Philippe Boulet. (2022) Global Initiative for Asthma Strategy 2021. Respirology 27:1, pages 14-35.
Crossref
Inge Raadal Skov, Daniel Pilsgaard Henriksen, Hanne Madsen, Anton Pottegård & Jesper Rømhild Davidsen. (2021) Changes in oral corticosteroid use in asthma treatment—A 20‐year Danish nationwide drug utilisation study. Basic & Clinical Pharmacology & Toxicology 130:1, pages 122-131.
Crossref
Adel H. Mansur. (2022) Effect of benralizumab in a patient with uncontrolled severe eosinophilic asthma and comorbid chronic rhinosinusitis with nasal polyps refractory to mepolizumab treatment. Respiratory Medicine Case Reports 35, pages 101559.
Crossref
Helen K. Reddel, Eric D. Bateman, Michael Schatz, Jerry A. Krishnan & Michelle M. Cloutier. (2022) A Practical Guide to Implementing SMART in Asthma Management. The Journal of Allergy and Clinical Immunology: In Practice 10:1, pages S31-S38.
Crossref
Helen K. Reddel, Leonard B. Bacharier, Eric D. Bateman, Christopher E. Brightling, Guy G. Brusselle, Roland Buhl, Alvaro A. Cruz, Liesbeth Duijts, Jeffrey M. Drazen, J. Mark FitzGerald, Louise J. Fleming, Hiromasa Inoue, Fanny W. Ko, Jerry A. Krishnan, Mark L. Levy, Jiangtao Lin, Kevin Mortimer, Paulo M. Pitrez, Aziz Sheikh, Arzu A. Yorgancioglu & Louis-Philippe Boulet. (2022) Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes. The Journal of Allergy and Clinical Immunology: In Practice 10:1, pages S1-S18.
Crossref
Helen K. Reddel, Leonard B. Bacharier, Eric D. Bateman, Christopher E. Brightling, Guy G. Brusselle, Roland Buhl, Alvaro A. Cruz, Liesbeth Duijts, Jeffrey M. Drazen, J. Mark FitzGerald, Louise J. Fleming, Hiromasa Inoue, Fanny W. Ko, Jerry A. Krishnan, Mark L. Levy, Jiangtao Lin, Kevin Mortimer, Paulo M. Pitrez, Aziz Sheikh, Arzu A. Yorgancioglu & Louis-Philippe Boulet. (2022) Global Initiative for Asthma Strategy 2021. Executive Summary and Rationale for Key Changes. Archivos de Bronconeumología 58:1, pages 35-51.
Crossref
Eugene R. Bleecker, Hitesh Gandhi, Ileen Gilbert, Kevin R. Murphy & Geoffrey L. Chupp. (2022) Mapping geographic variability of severe uncontrolled asthma in the United States. Annals of Allergy, Asthma & Immunology 128:1, pages 78-88.
Crossref
Andrew Menzies-Gow, Mark Gurnell, Liam G Heaney, Jonathan Corren, Elisabeth H Bel, Jorge Maspero, Timothy Harrison, David J Jackson, David Price, Njira Lugogo, James Kreindler, Annie Burden, Alex de Giorgio-Miller, Kelly Padilla, Ubaldo J Martin & Esther Garcia Gil. (2022) Oral corticosteroid elimination via a personalised reduction algorithm in adults with severe, eosinophilic asthma treated with benralizumab (PONENTE): a multicentre, open-label, single-arm study. The Lancet Respiratory Medicine 10:1, pages 47-58.
Crossref
Korey DuBois & Jacob Wynes. 2022. Tendon and Ligament Injuries of the Foot and Ankle. Tendon and Ligament Injuries of the Foot and Ankle 175 194 .
Eric D. Bateman, Paul M. O’ByrneJ. Mark FitzGeraldPeter J. BarnesJinping ZhengRosa LamarcaMargareta PuuHimanshu Parikh, Vijay Alagappan & Helen K. Reddel. (2021) Positioning As-needed Budesonide–Formoterol for Mild Asthma: Effect of Prestudy Treatment in Pooled Analysis of SYGMA 1 and 2. Annals of the American Thoracic Society 18:12, pages 2007-2017.
Crossref
Silvano Dragonieri & Giovanna Elisiana Carpagnano. (2021) Biological therapy for severe asthma. Asthma Research and Practice 7:1.
Crossref
Zeyi Zhang, Jingjing Wang & Ou Chen. (2021) Identification of biomarkers and pathogenesis in severe asthma by coexpression network analysis. BMC Medical Genomics 14:1.
Crossref
Joanne E. Kavanagh, Andrew P. Hearn & David J. Jackson. (2022) A pragmatic guide to choosing biologic therapies in severe asthma. Breathe 17:4, pages 210144.
Crossref
David Watchorn & Andrew Menzies‐Gow. (2021) Oral corticosteroid stewardship for asthma: Time to move from theory to routine clinical practice. Respirology 26:12, pages 1094-1095.
Crossref
John Blakey, Li Ping Chung, Vanessa M. McDonald, Laurence Ruane, John Gornall, Chris Barton, Sinthia Bosnic‐Anticevich, John Harrington, Mark Hew, Anne E. Holland, Trudy Hopkins, Lata Jayaram, Helen Reddel, John W. Upham, Peter G. Gibson & Philip Bardin. (2021) Oral corticosteroids stewardship for asthma in adults and adolescents: A position paper from the Thoracic Society of Australia and New Zealand. Respirology 26:12, pages 1112-1130.
Crossref
Kelli Carneiro de Freitas Nakata, Luisa Daige Marques, Helder Cássio de Oliveira, Graciane Catarina Batista Magalhães, Ruberlei Godinho de Oliveira & Clóvis Botelho. (2021) Anti-Interleukin-5 in the Management of Eosinophilic Asthma: A Review of Effectiveness, Safety, and Budgetary Impact From the Perspective of the Brazilian Health System. Value in Health Regional Issues 26, pages 169-181.
Crossref
Stephanie Korn, Arnaud Bourdin, Geoffrey Chupp, Borja G. Cosio, Doug Arbetter, Mihir Shah & Esther Garcia Gil. (2021) Integrated Safety and Efficacy Among Patients Receiving Benralizumab for Up to 5 Years. The Journal of Allergy and Clinical Immunology: In Practice 9:12, pages 4381-4392.e4.
Crossref
J. Simmering, E.M. Stapleton, P.M. Polgreen, J. Kuntz & A.K. Gerke. (2021) Patterns of medication use and imaging following initial diagnosis of sarcoidosis. Respiratory Medicine 189, pages 106622.
Crossref
Vidushi Sood, Linda Rogers & Sandhya Khurana. (2021) Managing Corticosteroid-Related Comorbidities in Severe Asthma. Chest 160:5, pages 1614-1623.
Crossref
Lauren T. Roland, Alan Regenberg, Amber U. Luong, Sarah K. Wise, Elina Toskala, Kent K. Lam, Joshua M. Levy, Christine B. Franzese, Kristine Smith & Jean Kim. (2021) Biologics for chronic rhinosinusitis with nasal polyps: Economics and ethics. International Forum of Allergy & Rhinology 11:11, pages 1524-1528.
Crossref
Carey M. Suehs & Arnaud Bourdin. (2021) Tapering of Oral Corticosteroids for the Treatment of Asthma. Archivos de Bronconeumología 57:10, pages 621-622.
Crossref
Carey M. Suehs & Arnaud Bourdin. (2021) Tapering of Oral Corticosteroids for the Treatment of Asthma. Archivos de Bronconeumología (English Edition) 57:10, pages 621-622.
Crossref
Wenting Xu, Rui Zhao & Bin Yuan. (2021) The Therapeutic Effect of Traditional LiuJunZi Decoction on Ovalbumin-Induced Asthma in Balb/C Mice. Canadian Respiratory Journal 2021, pages 1-10.
Crossref
Hideaki Kadotani, Kazuhisa Asai, Atsushi Miyamoto, Kohei Iwasaki, Takahiro Kawai, Misako Nishimura, Mitsunori Tohda, Atsuko Okamoto, Kanako Sato, Kazuhiro Yamada, Naoki Ijiri, Tetsuya Watanabe & Tomoya Kawaguchi. (2021) The Fermented Soy Product ImmuBalanceTM Suppresses Airway Inflammation in a Murine Model of Asthma. Nutrients 13:10, pages 3380.
Crossref
Jingbo Qin, Mingsheng Lv, Zeqiang Jiang, Xianghe Meng, Yi Wang, Jiarui Cui, Ji Wang & Qi Wang. (2021) Tuo-Min-Ding-Chuan Decoction Alleviate Ovalbumin-Induced Allergic Asthma by Inhibiting Mast Cell Degranulation and Down-Regulating the Differential Expression Proteins. Frontiers in Pharmacology 12.
Crossref
Susan Mcclement. (2021) Adipose Tissue and Cancer Cachexia: What Nurses Need to Know. Asia-Pacific Journal of Oncology Nursing 8:5, pages 445-449.
Crossref
Gayatri B. Patel, Elizabeth A. Kudlaty, Amina Guo, Chen Yeh, Margaret S. Kim, Caroline P.E. Price, David Conley, Leslie C. Grammer, Ravi Kalhan, Robert C. Kern, Kris G. McGrath, Bruce K. Tan, Sharon R. Rosenberg, Robert P. Schleimer, Stephanie S. Smith, Whitney W. Stevens, Kevin C. Welch & Anju T. Peters. (2021) Impact of type 2 targeting biologics on acute exacerbations of chronic rhinosinusitis. Allergy and Asthma Proceedings 42:5, pages 417-424.
Crossref
Francesco Menzella, Carla Galeone, Giulia Ghidoni, Patrizia Ruggiero, Maria D'Amato, Matteo Fontana & Nicola Facciolongo. (2021) The pharmacoeconomics of the state-of-the-art drug treatments for asthma: a systematic review. Multidisciplinary Respiratory Medicine 16.
Crossref
M. Gurnell, L. G. Heaney, D. Price & A. Menzies‐Gow. (2021) Long‐term corticosteroid use, adrenal insufficiency and the need for steroid‐sparing treatment in adult severe asthma. Journal of Internal Medicine 290:2, pages 240-256.
Crossref
Arnaud Bourdin, Jérémy Charriot, Clément Boissin, Engi Ahmed, Carey Suehs, Arthur De Sevin, Mathilde Volpato, Laurie Pahus, Delphine Gras, Isabelle Vachier, Laurence Halimi, Dominic Hamerlijnck & Pascal Chanez. (2020) Will the asthma revolution fostered by biologics also benefit adult ICU patients?. Allergy 76:8, pages 2395-2406.
Crossref
Michael T. Chang & Peter H. Hwang. (2021) Challenging our assumptions: oral corticosteroids and chronic rhinosinusitis without nasal polyposis. International Forum of Allergy & Rhinology 11:8, pages 1149-1151.
Crossref
Pascal Demoly, Catherine Bos & Carmen Vidal. (2021) Worsening of chronic house-dust-mite-induced respiratory allergies: An observational survey in three European countries. World Allergy Organization Journal 14:7, pages 100563.
Crossref
Claudia Chaves Loureiro, Manuel Branco Ferreira, Jorge Ferreira, Ricardo Lima, João Marques, Anna Sokolova, Fernanda S. Tonin & Filipa Duarte Ramos. (2021) Reducing oral corticosteroids in severe asthma (ROSA Project): a nationwide Portuguese consensus. Pulmonology 27:4, pages 313-327.
Crossref
Dennis Thomas, Erin S. Harvey, Vanessa M. McDonald, Sean Stevens, John W. Upham, Constance H. Katelaris, Vicky Kritikos, Andrew Gillman, John Harrington, Mark Hew, Philip Bardin, Matthew Peters, Paul N. Reynolds, David Langton, Melissa Baraket, Jeffrey J. Bowden, Simon Bowler, Jimmy Chien, Li Ping Chung, Claude S. Farah, Christopher Grainge, Christine Jenkins, Gregory P. Katsoulotos, Joy Lee, Naghmeh Radhakrishna, Helen K. Reddel, Janet Rimmer, Pathmanathan Sivakumaran, Peter A.B. Wark & Peter G. Gibson. (2021) Mepolizumab and Oral Corticosteroid Stewardship: Data from the Australian Mepolizumab Registry. The Journal of Allergy and Clinical Immunology: In Practice 9:7, pages 2715-2724.e5.
Crossref
Ireti Adejumo & Dominick E. Shaw. (2021) Con: Access to advanced therapies for severe asthma should be restricted to patients with satisfactory adherence to maintenance treatment. Breathe 17:2, pages 210049.
Crossref
Vincent Brennan, Christopher Mulvey & Richard W. Costello. (2021) The clinical impact of adherence to therapy in airways disease. Breathe 17:2, pages 210039.
Crossref
Christos V. Chalitsios, Dominick E. Shaw & Tricia M. McKeever. (2021) Corticosteroids and bone health in people with asthma: A systematic review and meta-analysis. Respiratory Medicine 181, pages 106374.
Crossref
Engi Ahmed, Isabelle Vachier, Jérémy Charriot & Arnaud Bourdin. (2021) Identifier et prendre en charge l’asthme difficile. La Presse Médicale Formation 2:2, pages 159-165.
Crossref
Louis-Philippe Boulet & Krystelle Godbout. (2021) Oral Corticosteroids Tapering in Severe Asthma. American Journal of Respiratory and Critical Care Medicine 203:7, pages 795-796.
Crossref
Carey M. Suehs, Andrew Menzies-Gow, David Price, Eugene R. Bleecker, Giorgio Walter Canonica, Mark Gurnell & Arnaud Bourdin. (2021) Expert Consensus on the Tapering of Oral Corticosteroids for the Treatment of Asthma. A Delphi Study. American Journal of Respiratory and Critical Care Medicine 203:7, pages 871-881.
Crossref
Dermot Ryan, Heath Heatley, Liam G. Heaney, David J. Jackson, Paul E. Pfeffer, John Busby, Andrew N. Menzies-Gow, Rupert Jones, Trung N. Tran, Mona Al-Ahmad, Vibeke Backer, Manon Belhassen, Sinthia Bosnic-Anticevich, Arnaud Bourdin, Lakmini Bulathsinhala, Victoria Carter, Isha Chaudhry, Neva Eleangovan, J. Mark FitzGerald, Peter G. Gibson, Naeimeh Hosseini, Alan Kaplan, Ruth B. Murray, Chin Kook Rhee, Eric Van Ganse & David B. Price. (2021) Potential Severe Asthma Hidden in UK Primary Care. The Journal of Allergy and Clinical Immunology: In Practice 9:4, pages 1612-1623.e9.
Crossref
Patrick W. Sullivan, Vahram H. Ghushchyan, David P. Skoner, Jason LeCocq, Siyeon Park & Robert S. Zeiger. (2021) Complications and Health Care Resource Utilization Associated with Systemic Corticosteroids in Children and Adolescents with Persistent Asthma. The Journal of Allergy and Clinical Immunology: In Practice 9:4, pages 1541-1551.e9.
Crossref
J. Mark FitzGerald, Paul M. O’Byrne, Eric D. Bateman, Peter J. Barnes, Jinping Zheng, Stefan Ivanov, Rosa Lamarca, Ulrika Larsdotter, Ulrika Emerath, Gerreke Jansen, Margareta Puu, Vijay K. T. Alagappan, Filip Surmont & Helen K. Reddel. (2021) Safety of As-Needed Budesonide-Formoterol in Mild Asthma: Data from the Two Phase III SYGMA Studies. Drug Safety 44:4, pages 467-478.
Crossref
Holly Tibble, Mary Flook, Aziz Sheikh, Athanasios Tsanas, Rob Horne, Bernard Vrijens, Sabina De Geest & Helen R. Stagg. (2020) Measuring and reporting treatment adherence: What can we learn by comparing two respiratory conditions?. British Journal of Clinical Pharmacology 87:3, pages 825-836.
Crossref
Ludger Klimek, Marek Jutel, Jean Bousquet, Ioana Agache, Cezmi A. Akdis, Valerie Hox, Philippe Gevaert, Peter Valentin Tomazic, Carmen Rondon, Cemal Cingi, Sanna Toppila‐Salmi, Aspasia Karavelia, Banu Bozkurt, Ulrike Förster‐Ruhrmann, Sven Becker, Adam M. Chaker, Barbara Wollenberg, Ralph Mösges, Tilman Huppertz, Jan Hagemann, Claus Bachert & Wytske Fokkens. (2021) Management of patients with chronic rhinosinusitis during the COVID‐19 pandemic—An EAACI position paper. Allergy 76:3, pages 677-688.
Crossref
Giulia Scioscia, Giovanna Elisiana Carpagnano, Carla Maria Irene Quarato, Donato Lacedonia, Sonia Santamaria, Piera Soccio, Annarita Depalo, Paolo Fuso & Maria Pia Foschino Barbaro. (2021) Effectiveness of Benralizumab in Improving the Quality of Life of Severe Eosinophilic Asthmatic Patients: Our Real-Life Experience. Frontiers in Pharmacology 12.
Crossref
Kanokvalai Kulthanan, Patompong Ungprasert, Sompol Tapechum, Chuda Rujitharanawong, Rungsima Kiratiwongwan, Kanyalak Munprom, Dorothea Terhorst-Molawi & Marcus Maurer. (2021) Vibratory Angioedema Subgroups, Features, and Treatment: Results of a Systematic Review. The Journal of Allergy and Clinical Immunology: In Practice 9:2, pages 971-984.
Crossref
Hitasha Rupani. (2021) Time for a Paradigm Shift. Chest 159:2, pages 459-461.
Crossref
Paul M O'Byrne, J Mark FitzGerald, Eric D Bateman, Peter J Barnes, Jinping Zheng, Per Gustafson, Rosa Lamarca, Margareta Puu, Christina Keen, Vijay K T Alagappan & Helen K Reddel. (2021) Effect of a single day of increased as-needed budesonide–formoterol use on short-term risk of severe exacerbations in patients with mild asthma: a post-hoc analysis of the SYGMA 1 study. The Lancet Respiratory Medicine 9:2, pages 149-158.
Crossref
Christos V Chalitsios, Dominick E Shaw & Tricia M McKeever. (2021) Risk of osteoporosis and fragility fractures in asthma due to oral and inhaled corticosteroids: two population-based nested case-control studies. Thorax 76:1, pages 21-28.
Crossref
Hyun Lee, Sang‐Heon Kim, Byung‐Keun Kim, Youngsoo Lee, Hwa Young Lee, Ga‐Young Ban, Min‐Hye Kim, Joo‐Hee Kim, Jae‐Woo Kwon, So‐Young Park, Jae‐Woo Jung, So Young Park, Chan Sun Park, Chin Kook Rhee, Taehoon Lee, Jae‐Hyun Lee, So Ri Kim, Jong‐Sook Park, Heung‐Woo Park, Kwang Ha Yoo, Yeon‐Mok Oh, Young‐Il Koh, Byung‐Jae Lee, An‐Soo Jang, Sang‐Heon Cho, Hae‐Sim Park, Choon‐Sik Park, You Sook Cho & Ho Joo Yoon. (2020) Characteristics of Specialist‐Diagnosed Asthma‐COPD Overlap in Severe Asthma: Observations from the Korean Severe Asthma Registry (KoSAR). Allergy 76:1, pages 223-232.
Crossref
Marek Lommatzsch, Inessa Schwab Sauerbeck, Cristina Wilmer & Christian Taube. (2021) Oral corticosteroid prescription for asthma by general practitioners: A three-year analysis in Germany. Respiratory Medicine 176, pages 106242.
Crossref
John Davison & Simon Doe. (2021) A patient case demonstrating the efficacy of benralizumab in uncontrolled severe eosinophilic asthma refractory to omalizumab and mepolizumab treatment. Respiratory Medicine Case Reports 34, pages 101557.
Crossref
Anne L. Fuhlbrigge & Sunita Sharma. (2021) Oral Corticosteroid Use in Asthma: A Wolf in Sheep's Clothing. The Journal of Allergy and Clinical Immunology: In Practice 9:1, pages 347-348.
Crossref
P. Jane McDowell, John H. Stone, Yuqing Zhang, Kirsty Honeyford, Louise Dunn, R. Jayne Logan, Claire A. Butler, Lorcan P.A. McGarvey & Liam G. Heaney. (2021) Quantification of Glucocorticoid-Associated Morbidity in Severe Asthma Using the Glucocorticoid Toxicity Index. The Journal of Allergy and Clinical Immunology: In Practice 9:1, pages 365-372.e5.
Crossref
Trung N. Tran, Sharon MacLachlan, Wesley Hicks, Jieruo Liu, Yen Chung, James Zangrilli, Annalisa Rubino & Michael L. Ganz. (2021) Oral Corticosteroid Treatment Patterns of Patients in the United States with Persistent Asthma. The Journal of Allergy and Clinical Immunology: In Practice 9:1, pages 338-346.e3.
Crossref
Michael E. Wechsler, Gene Colice, Janet M. Griffiths, Gun Almqvist, Tor Skärby, Teresa Piechowiak, Primal Kaur, Karin Bowen, Åsa Hellqvist, May Mo & Esther Garcia Gil. (2020) SOURCE: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel group trial to evaluate the efficacy and safety of tezepelumab in reducing oral corticosteroid use in adults with oral corticosteroid dependent asthma. Respiratory Research 21:1.
Crossref
Pere Casan Clarà & Cristina Martínez González. (2020) Dosis acumulada de corticoides sistémicos: una información relevante en medicina. Archivos de Bronconeumología 56:12, pages 777-778.
Crossref
Pere Casan Clarà & Cristina Martínez González. (2020) Accumulated Dose of Systemic Corticosteroids: Significant Medical Information. Archivos de Bronconeumología (English Edition) 56:12, pages 777-778.
Crossref
E. Ahmed, Z.M. Lahmar, J. Charriot & A. Bourdin. (2020) Effet de la corticothérapie orale au long cours chez les patients asthmatiques sévères de type T2. Revue des Maladies Respiratoires Actualités 12:2, pages 2S398-2S408.
Crossref
Michael S. Blaiss. (2020) Chronic rhinosinusitis with nasal polyps management in the age of biologics. Allergy and Asthma Proceedings 41:6, pages 413-419.
Crossref
Florence N Schleich, Andrei Malinovschi, Anne Chevremont, Laurence Seidel & Renaud Louis. (2020) Risk factors associated with frequent exacerbations in asthma. Respiratory Medicine: X 2, pages 100022.
Crossref
Robert Zeiger, Patrick Sullivan, Yen Chung, James L. Kreindler, Nicole M. Zimmerman & Joseph Tkacz. (2020) Systemic Corticosteroid-Related Complications and Costs in Adults with Persistent Asthma. The Journal of Allergy and Clinical Immunology: In Practice 8:10, pages 3455-3465.e13.
Crossref
Mark Hew, Vanessa M McDonald, Phil G Bardin, Li Ping Chung, Claude S Farah, Amanda Barnard, Mark S Cooper, Peter G Gibson & John W Upham. (2020) Cumulative dispensing of high oral corticosteroid doses for treating asthma in Australia. Medical Journal of Australia 213:7, pages 316-320.
Crossref
Andrew P. Hearn, Brian D. Kent & David J. Jackson. (2020) Biologic treatment options for severe asthma. Current Opinion in Immunology 66, pages 151-160.
Crossref
Wendy C. Moore, Reynold A. PanettieriJr.Jr., Jennifer Trevor, Dennis K. Ledford, Njira Lugogo, Weily Soong, Bradley E. Chipps, Warner Carr, Laura Belton, Hitesh Gandhi, Frank Trudo & Christopher S. Ambrose. (2020) Biologic and maintenance systemic corticosteroid therapy among US subspecialist-treated patients with severe asthma. Annals of Allergy, Asthma & Immunology 125:3, pages 294-303.e1.
Crossref
Kazuto Matsunaga, Mitsuru Adachi, Hiroyuki Nagase, Tomoko Okoba, Nobuya Hayashi & Yuji Tohda. (2020) Association of low-dosage systemic corticosteroid use with disease burden in asthma. npj Primary Care Respiratory Medicine 30:1.
Crossref
J. Mark FitzGerald, Peter J. Barnes, Bradley E. Chipps, Christine R. Jenkins, Paul M. O'Byrne, Ian D. Pavord & Helen K. Reddel. (2020) The burden of exacerbations in mild asthma: a systematic review. ERJ Open Research 6:3, pages 00359-2019.
Crossref
Kjell Larsson, Hannu Kankaanranta, Christer Janson, Lauri Lehtimäki, Björn Ställberg, Anders Løkke, Kristian Høines, Klaus Roslind & Charlotte Suppli Ulrik. (2020) Bringing asthma care into the twenty-first century. npj Primary Care Respiratory Medicine 30:1.
Crossref
Trung N. Tran, Elizabeth King, Rajiv Sarkar, Cassandra Nan, Annalisa Rubino, Caroline O'Leary, Ruvimbo Muzwidzwa, Laura Belton & Jennifer K. Quint. (2020) Oral corticosteroid prescription patterns for asthma in France, Germany, Italy and the UK. European Respiratory Journal 55:6, pages 1902363.
Crossref
Davide L. Vetrano, Alberto Zucchelli, Elisa Bianchini, Ettore Marconi, Francesco P. Lombardo, Claudio Cricelli & Francesco Lapi. (2020) Patterns of oral corticosteroids use in primary care patients with severe asthma. Respiratory Medicine 166, pages 105946.
Crossref
Arnaud Bourdin, Don Husereau, Nicolas Molinari, Sarowar Golam, Mohd Kashif Siddiqui, Leandro Lindner & Xiao Xu. (2020) Matching‐adjusted comparison of oral corticosteroid reduction in asthma: Systematic review of biologics. Clinical & Experimental Allergy 50:4, pages 442-452.
Crossref
David Price, Mario Castro, Arnaud Bourdin, Sebastian Fucile & Pablo Altman. (2020) Short-course systemic corticosteroids in asthma: striking the balance between efficacy and safety. European Respiratory Review 29:155, pages 190151.
Crossref
Arnaud Bourdin, Ian Adcock, Patrick Berger, Philippe Bonniaud, Philippe Chanson, Cécile Chenivesse, Jacques de Blic, Antoine Deschildre, Philippe Devilliers, Gilles Devouassoux, Alain Didier, Gilles Garcia, Antoine Magnan, Yan Martinat, Thierry Perez, Nicolas Roche, Camille Taillé, Pierre Val & Pascal Chanez. (2020) How can we minimise the use of regular oral corticosteroids in asthma?. European Respiratory Review 29:155, pages 190085.
Crossref
Eugene R. Bleecker, Andrew N. Menzies-Gow, David B. Price, Arnaud Bourdin, Stephen Sweet, Amber L. Martin, Marianna Alacqua & Trung N. Tran. (2020) Systematic Literature Review of Systemic Corticosteroid Use for Asthma Management. American Journal of Respiratory and Critical Care Medicine 201:3, pages 276-293.
Crossref
Bruce Kirenga, Jeremiah Chakaya, Getnet Yimer, George Nyale, Tewodros Haile, Winters Muttamba, Levicatus Mugenyi, Winceslaus Katagira, William Worodria, Hellen Aanyu-Tukamuhebwa, Njira Lugogo, Moses Joloba, Amsalu Bekele, Fred Makumbi, Cindy Green, Corina de Jong, Moses Kamya & Thys van der Molen. (2020) Phenotypic characteristics and asthma severity in an East African cohort of adults and adolescents with asthma: findings from the African severe asthma project. BMJ Open Respiratory Research 7:1, pages e000484.
Crossref
Li Ping Chung, John W. Upham, Philip G. Bardin & Mark Hew. (2019) Rational oral corticosteroid use in adult severe asthma: A narrative review. Respirology 25:2, pages 161-172.
Crossref
Marek Lommatzsch. (2020) Immune Modulation in Asthma: Current Concepts and Future Strategies. Respiration 99:7, pages 566-576.
Crossref
Charlotte Suppli Ulrik, Susanne Vijverberg, Nicola A. Hanania & Zuzana Diamant. (2020) Precision medicine and treatable traits in chronic airway diseases - where do we stand?. Current Opinion in Pulmonary Medicine 26:1, pages 33-39.
Crossref
Carlo Lombardi, Francesco Menzella & Giovanni Passalacqua. (2020) Long-term responsiveness to mepolizumab after failure of omalizumab and bronchial thermoplasty: Two triple-switch case reports. Respiratory Medicine Case Reports 29, pages 100967.
Crossref
Ana Sá-Sousa, Rute Almeida, Ricardo Vicente, Nilton Nascimento, Henrique Martins, Alberto Freitas & João Almeida Fonseca. (2019) High oral corticosteroid exposure and overuse of short-acting beta-2-agonists were associated with insufficient prescribing of controller medication: a nationwide electronic prescribing and dispensing database analysis. Clinical and Translational Allergy 9:1.
Crossref
Sarah A. Hiles, Vanessa M. McDonald, Michelle Guilhermino, Guy G. Brusselle & Peter G. Gibson. (2019) Does maintenance azithromycin reduce asthma exacerbations? An individual participant data meta-analysis. European Respiratory Journal 54:5, pages 1901381.
Crossref
Hyun Lee, Jiin Ryu, Eunwoo Nam, Sung Jun Chung, Yoomi Yeo, Dong Won Park, Tai Sun Park, Ji-Yong Moon, Tae-Hyung Kim, Jang Won Sohn, Ho Joo Yoon & Sang-Heon Kim. (2019) Increased mortality in patients with corticosteroid-dependent asthma: a nationwide population-based study. European Respiratory Journal 54:5, pages 1900804.
Crossref
Richard J. Martin, Elisabeth H. Bel, Ian D. Pavord, David Price & Helen K. Reddel. (2019) Defining severe obstructive lung disease in the biologic era: an endotype-based approach. European Respiratory Journal 54:5, pages 1900108.
Crossref
Magnus Ekström, Bright I. Nwaru, Pål Hasvold, Fredrik Wiklund, Gunilla Telg & Christer Janson. (2019) Oral corticosteroid use, morbidity and mortality in asthma: A nationwide prospective cohort study in Sweden. Allergy 74:11, pages 2181-2190.
Crossref
Arnaud Bourdin, Leif Bjermer, Christopher Brightling, Guy G. Brusselle, Pascal Chanez, Kian Fan Chung, Adnan Custovic, Zuzana Diamant, Sarah Diver, Ratko Djukanovic, Dominique Hamerlijnck, Ildikó Horváth, Sebastian L. Johnston, Frank Kanniess, Nikos Papadopoulos, Alberto Papi, Richard J. Russell, Dermot Ryan, Konstantinos Samitas, Thomy Tonia, Eleftherios Zervas & Mina Gaga. (2019) ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions. European Respiratory Journal 54:3, pages 1900900.
Crossref
Kamonpun Ussavarungsi & Alicia K. Gerke. (2019) Approach to tapering antisarcoidosis therapy. Current Opinion in Pulmonary Medicine 25:5, pages 526-532.
Crossref
Qi Shi, Dongxu Si, Haipeng Bao, Yue Yan, Yanhua Kong, Chunlei Li, Wenfeng He, Dashzeveg Damchaaperenlei, Mingxia Yu & Youlin Li. (2019) Efficacy and safety of Chinese medicines for asthma. Medicine 98:34, pages e16958.
Crossref
Andrew Menzies-Gow, Jonathan Corren, Elisabeth H. Bel, Jorge Maspero, Liam G. Heaney, Mark Gurnell, Peter Wessman, Ubaldo J. Martin, Shahid Siddiqui & Esther Garcia Gil. (2019) Corticosteroid tapering with benralizumab treatment for eosinophilic asthma: PONENTE Trial. ERJ Open Research 5:3, pages 00009-2019.
Crossref

Displaying 200 of 204 citing articles. Use the download link below to view the full list of citing articles.

Download full citations list

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.